Healthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Healthpeak Properties, Inc. (NYSE:DOC) has received an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $22.86.

Several equities analysts recently commented on the stock. Wedbush increased their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Evercore ISI raised their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, September 16th. Finally, Royal Bank of Canada boosted their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $22.51 on Wednesday. The business’s fifty day simple moving average is $22.30 and its 200-day simple moving average is $20.89. The company has a market cap of $15.74 billion, a PE ratio of 47.89, a PEG ratio of 2.45 and a beta of 1.13. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties has a 12-month low of $15.44 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). The business had revenue of $700.40 million for the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.45 earnings per share. Analysts expect that Healthpeak Properties will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.33%. The ex-dividend date of this dividend is Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is 255.32%.

Institutional Trading of Healthpeak Properties

A number of hedge funds have recently added to or reduced their stakes in DOC. Point72 Asia Singapore Pte. Ltd. purchased a new position in Healthpeak Properties in the second quarter valued at $66,000. Point72 DIFC Ltd purchased a new position in shares of Healthpeak Properties in the 2nd quarter valued at about $161,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Healthpeak Properties in the 2nd quarter worth about $9,024,000. Centaurus Financial Inc. purchased a new position in Healthpeak Properties during the second quarter worth approximately $227,000. Finally, Massmutual Trust Co. FSB ADV acquired a new stake in Healthpeak Properties in the third quarter valued at approximately $108,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.